Verano Holdings Corp. (NEOE: VRNO)
Health Care · Pharmaceuticals · US
CA$5.81
-5.53% today · -12.6% 1Y
Verano Holdings Corp. (NEOE: VRNO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $297.33M and employs 3,800 people.
Over the last twelve months the share price has lost 12.6%, trading between 5.50 and 13.30.
Tweenvest scores Verano Holdings Corp. across four factors: quality 52/100, value 71/100, growth 25/100. Its strongest factor is value.
VRNO price history
Key figures
- Market cap
- $297.33M
- Revenue (TTM)
- $845.15M
- P/E
- -1.36
- EPS
- -4.29
- Dividend yield
- —
- Beta (5Y)
- 1.54
- 52-week high
- CA$13.30
- 52-week low
- CA$5.50
- Avg volume (3M)
- —
- Shares outstanding
- 72.93M
- Employees
- 3,800
- Next earnings
- —
About Verano Holdings Corp.
Verano Holdings Corp. functions as a vertically integrated, multi-state cannabis enterprise throughout the United States. Its operations span the complete cannabis supply chain, from growing and manufacturing to wholesale and direct-to-consumer sales, across a broad geographic range. This includes Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company provides a variety of artisanal cannabis products, sold under prominent brands such as Encore, Avexia, MUV, Savvy, BITS, and Verano, to cater to both medical and adult-use markets. Its headquarters are located in Chicago, Illinois.
- ISIN
- US92339H2004
- Listed since
- Feb 17, 2021
- Exchange
- Aequitas Neo Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gulf Pharmaceutical Industries P.S.C.ADX: JULPHAR | $301.95M | AED0.96 | +1.05% |
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $300.21M | CN¥22.62 | -1.22% |
| Biofarm S.A.BVB: BIO | $299.92M | RON1.37 | +0.74% |
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $299.47M | NT$55.30 | +0.36% |
| Hubei Guangji Pharmaceutical Co., Ltd.SZSE: 000952 | $292.72M | CN¥5.68 | -1.73% |
| Hikal LimitedBSE: 524735 | $291.09M | Rs222.60 | -0.47% |
| Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.SHSE: 603168 | $290.86M | CN¥5.19 | -0.57% |
| Aurora Cannabis Inc.TSX: ACB | $289.46M | CA$6.31 | -2.47% |